Scientific Committees for Candidate Prioritization

Why Candidate Prioritization Needs a Defined Process

A platform may receive proposals for several candidate interventions while having limited scientific review capacity, operational bandwidth, and room for a coherent research portfolio. A scientific committee can help compare those candidates in a consistent way. Its purpose is to assess scientific merit and relative priority, not to turn a favorable discussion into permission to proceed.

The distinction matters because prioritization and authorization answer different questions. A scientific recommendation addresses which candidate appears most worth advancing for further consideration, given the evidence, feasibility, and portfolio context reviewed. An authorized decision addresses whether the responsible decision-maker permits a specified action. As established in the earlier material on decision rights and delegation, authority should remain with the role assigned that responsibility; a committee’s recommendation does not itself transfer that authority.

A sound process makes the committee’s remit explicit before it reviews candidates. It states what kind of recommendation is requested, what evidence and criteria are in scope, who receives the recommendation, and which decision-maker retains final authority. This prevents an apparent ranking from being mistaken for a decision that the committee is not empowered to make.

Set Up a Review That Can Be Compared Fairly

The committee should receive a consistent summary for each candidate. At minimum, the summary identifies the proposed intervention and intended population, the clinical question it is meant to address, the main supporting evidence, important uncertainties, resource and delivery requirements, and its relationship to interventions already under consideration. Where possible, the same time window, population assumptions, and level of detail should be used for every candidate.

Evidence review should distinguish at least four questions: how credible the evidence is, how directly it applies to the proposed population and setting, how large and clinically relevant the apparent benefit may be, and what material uncertainties remain. These questions are related but not interchangeable. A promising result from a small or poorly matched study may warrant interest while still providing limited support for the proposed use. Conversely, a feasible candidate need not be scientifically compelling merely because it is easy to deliver.

Feasibility review considers whether the candidate can realistically be evaluated in the proposed context. Relevant considerations may include supply, administration, monitoring, training, recruitment implications, and the time and data requirements needed for interpretable evaluation. Portfolio fit asks whether the candidate addresses an important gap, adds useful diversity, overlaps substantially with existing work, or competes for the same limited participants or resources. These are judgments that should be explained in context, not reduced to vague labels such as “good fit.”

Before comparing candidates, the committee should agree on shared criteria and anchored rating descriptions. A small rating scale can make differences visible, but a number is only a disciplined summary of judgment; it is not a measurement with guaranteed precision. The committee should keep short written reasons alongside each rating, record uncertainty and missing information, and permit members to challenge a rating when the evidence does not support its assigned level.

A Transparent Comparison Framework

One practical approach is a structured evidence-and-discussion matrix. It keeps distinct dimensions visible rather than allowing an impressive result in one area to obscure weaknesses elsewhere. A committee may also use a weighted summary score to organize discussion, provided that the scale, weights, and limits are disclosed. The score should support deliberation, not substitute for it.

Suppose each candidate receives ratings from 1 to 5 for evidence, feasibility, and portfolio fit, where higher is more favorable. Let the corresponding weights be \(w_E\), \(w_F\), and \(w_P\), with nonnegative values that sum to 1. A weighted summary is:

This calculation is meaningful as a summary only if the committee has agreed what the ratings and weights represent. It also imposes a substantive assumption: strength in one dimension can compensate for weakness in another. That may be useful for an initial comparison, but it is not automatically acceptable. A serious unresolved concern should not disappear because a candidate scores well on unrelated dimensions. Such concerns need to be described and handled under the applicable decision process, rather than hidden in an average.

The committee should compare the full profile as well as the summary. A candidate with a high score driven by feasibility but weak evidence has a different scientific case from one with strong evidence but substantial delivery challenges. If small changes in weights reverse the ranking, the result is sensitive to committee priorities; that sensitivity is useful information to report, not a reason to present a single ranking as definitive.

Test the Recommendation, Not Just the Arithmetic

A ranking is more credible when the committee checks whether it depends on arbitrary choices. One useful diagnostic is a sensitivity analysis: recalculate the summary under other plausible weights and ask whether the ordering changes. The calculation does not establish which weights are correct. It shows whether the recommendation is robust to reasonable differences in emphasis.

Other diagnostics include checking whether reviewers interpreted the anchors consistently, whether one candidate received more complete information than another, and whether a rating rests on evidence that is indirect or outdated for the intended population. Large disagreement between reviewers is a signal to clarify assumptions or examine evidence, not simply average the ratings and move on. A summary table should preserve the disagreement where it is relevant.

From Review to a Bounded Recommendation

A useful process moves from consistent information to explicit judgment, then to a recommendation that states its limits. The sequence below provides a practical structure.

What the Record Should Preserve

A review record should allow the recipient to understand not only the final ordering but how it was reached. Record the committee’s remit, materials reviewed, criteria and anchors, weights if used, ratings and their rationales, major uncertainties, sensitivity checks, conflicts relevant to the discussion, and any material disagreement. The recommendation should identify its intended audience and explicitly distinguish advice from a final decision.

Conflicts should be managed under the applicable governance arrangements and documented so that the basis of the discussion is interpretable. A member’s relevant expertise can be valuable, but an undisclosed or unmanaged competing interest can undermine confidence in the process. The committee should also avoid presenting a consensus label as proof that uncertainty has disappeared. When members disagree, a concise record of the principal alternative view may be more informative than a forced unanimous score.

Structured scoring is not the only reasonable method. A qualitative deliberation can be preferable when criteria are difficult to quantify, the evidence is sparse, or ratings would create a false impression of precision. Conversely, a matrix can improve consistency when many candidates must be reviewed or when comparisons otherwise depend on memory. Neither method removes judgment. A scorecard should be used to organize discussion, while a narrative should make the reasoning and limits visible.

Common Pitfalls and Limitations

• Treating the top-ranked candidate as approved. A ranking is a recommendation within the committee’s remit; authorization belongs to the designated decision-maker.
• Using precise-looking scores without meaningful anchors. Ratings are judgments. Define them in advance and retain the reasons behind them.
• Allowing a weighted average to hide a major concern. A strong result on one dimension may mathematically offset a weak one. Show the dimension-level profile and surface material concerns directly.
• Changing weights after seeing the ranking. This invites outcome-driven scoring. Set weights before comparison or clearly explain a principled revision and show its consequences.
• Comparing unequal evidence packages as if they were equivalent. Note missing, indirect, or differently timed information, and avoid interpreting an information advantage as a scientific advantage.
• Reporting only consensus. Meaningful uncertainty and dissent help decision-makers understand how stable the advice is.

A prioritization exercise is necessarily limited by its evidence base, its criteria, and the committee’s understanding of the portfolio at that time. It does not prove an intervention works, guarantee operational success, or decide questions outside its assigned remit. Its value is a traceable, context-aware comparison that helps an authorized decision-maker see the scientific trade-offs.